Trial Profile

Real-World Camzyos Patient Reported OutcoMes Through PAtient SurveyS in Hypertrophic CardioMyopathy (COMPASS-HCM): A Prospective Longitudinal Study

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

23 Mar 2026 According to Bristol Myers Squibb media release, data from this trial will be presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo, taking place March 28-30, 2026, in New Orleans, Louisiana.
03 Nov 2025 According to Bristol Myers Squibb media release, data from this trial will be presented at the American Heart Association's Scientific Sessions 2025, taking place November 7-10, 2025 in New Orleans, Louisiana.
17 Apr 2025 According to Bristol Myers Squibb media release, the U.S. Food and Drug Administration (FDA) has updated the U.S. Prescribing Information for CAMZYOS,The approved label update is supported by this trial.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com